Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
02:55pm, Wednesday, 07'th Jan 2026
NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Why The ‘Magnificent 7' Is Out In 2026 And These 3 Dividends Are ‘In'
12:00pm, Wednesday, 07'th Jan 2026
Ignore the doom-and-gloom “predictions” about 2026. There are plenty of gains—and growing dividends—to be had for us this year.
Waters-Becton Dickinson Deal May Deliver Bigger Gains Than Expected: Analyst
01:48pm, Tuesday, 06'th Jan 2026
In July 2025, Becton, Dickinson and Company (NYSE: BDX) agreed to combine its Biosciences & Diagnostic Solutions business with Waters Corporation (NYSE: WAT).
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
06:50am, Monday, 05'th Jan 2026
FRANKLIN LAKES, N.J., Jan. 5, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a significant milestone in its advanced tissu
Best Dividend Aristocrats For January 2026
08:47am, Wednesday, 31'st Dec 2025
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%
Best Dividend Kings: December 2025
06:44am, Sunday, 28'th Dec 2025
Dividend Kings underperformed SPY in 2025, up 4.47% vs. SPY's 17.7%, but select Kings outperformed the index. Twenty-two Dividend Kings are identified as both potentially undervalued and offering long
BD and Penn Institute Ink Collaboration to Advance Immunotherapy
01:16pm, Monday, 22'nd Dec 2025
BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 18'th Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
06:50am, Thursday, 18'th Dec 2025
BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study FRANKLIN LAKES, N
The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners
02:20pm, Wednesday, 17'th Dec 2025
Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.
BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe
12:41pm, Tuesday, 16'th Dec 2025
BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
04:40pm, Monday, 15'th Dec 2025
FRANKLIN LAKES, N.J. , Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and s
Market Today: IBM buys Confluent; Nvidia wins China chip nod
05:33pm, Monday, 08'th Dec 2025
Stock News Paramount escalates WBD fight: Paramount Skydance (PSKY) launched a hostile all-cash $30 per share tender offer for Warner Bros. Discovery (WBD), val
First Look: IBM nears Confluent deal; Berkshire reshuffle
07:37am, Monday, 08'th Dec 2025
Stock News China's trade surplus tops $1T YTD: China's exports rose 5.9% in November while imports grew 1.9%, pushing the 11âmonth surplus to nearly $1.08 tri
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
12:56pm, Friday, 05'th Dec 2025
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
